European Foundation for the Study of Diabetes

🇩🇪Germany

Country: 🇩🇪Germany

Ownership: -

Employees: -

Market Cap: -

Website: http://www.europeandiabetesfoundation.org/

Clinical Trials

Protective Effects of Sitagliptin on β Cell Function in Patients With Adult-onset Latent Autoimmune Diabetes (LADA)

Phase 1

Completed

Conditions: Type 1 Diabetes

Interventions: Drug: Insulin
Drug: sitagliptin

First Posted Date: 2010-07-12

Last Posted Date: 2018-07-31

Lead Sponsor: European Foundation for the Study of Diabetes

Target Recruit Count: 30

Registration Number: NCT01159847

Locations: 🇨🇳
Diabetes Center, Institute of Metabolism and Endocrinology, Second Xiangya Hospital, Central South University, Changsha, Hunan, China

Prev
1
Next

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy